Skip to main content
. Author manuscript; available in PMC: 2013 Jun 10.
Published in final edited form as: J Psychiatr Res. 2010 Jun 2;45(1):96–103. doi: 10.1016/j.jpsychires.2010.04.032

Table 3.

Remission or response in continuation phase by week 10 clinician-patient assessment discrepancy.

Visit Patient Category at Week 10 Remission
Response
HAM-D17 CGI-S IDS-SR HAM-D17 CGI-C IDS-SR












Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%)
Month 6 Concordant 275 (83) 56 (17) 299 (91) 31 (9) 234 (71) 97 (29) 314 (95) 17 (5) 299 (91) 31 (9) 277 (84) 54 (16)
Nonconcordant 71 (68) 33 (32) 82 (79) 22 (21) 59 (57) 45 (43) 97 (93) 7 (7) 82 (79) 22 (21) 71 (68) 33 (32)
Final Visit Concordant 379 (76) 123 (24) 415 (83) 87 (17) 321 (64) 180 (36) 451 (90) 51* (10) 415 (83) 87 (17) 389 (78) 112 (22)
Nonconcordant 104 (59) 72 (41) 124 (70) 52 (30) 88 (50) 87 (50) 146 (83) 30 (17) 124 (70) 52 (30) 107 (61) 68 (39)

CGI-S = Clinical Global Impression—Severity; HAM-D17= 17-item Hamilton Rating Scale for Depression; IDS-SR = Inventory of Depressive Symptomatology–Self-Report; ITT = intent to treat.

Remission is defined as: HAM-D17≤ 7; CGI-S ≤2; IDS-SR ≤ 14.

Response is defined as: HAM-D17 decrease ≥50% from acute phase baseline; CGI-C ≤ 2; IDS-SR decrease ≥50% or more from acute phase baseline.

*

P≤ 0.05 from Mantel-Haenszel chi-square test concordance-rater vs nonconcordance.

P≤ 0.01 from Mantel-Haenszel chi-square test concordance-rater vs nonconcordance.

P< 0.001 from Mantel-Haenszel chi-square test concordance-rater vs nonconcordance.

HHS Vulnerability Disclosure